Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study.

Source:http://linkedlifedata.com/resource/pubmed/id/8040675

Download in:

View as

General Info

PMID
8040675